KELSEY CRAMER: Open Payments
NPI 1114418159 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,813 in 15 payments from 6 companies in 2025. Trend: 2023 $360 · 2024 $1,952 · 2025 $2,813
Consulting: $1,700Food & beverage: $973Travel & lodging: $140
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $2,265 |
| Actelion Pharmaceuticals US, Inc. | 3 | $216 |
| GENZYME CORPORATION | 1 | $141 |
| United Therapeutics Corporation | 1 | $125 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| Philips North America LLC | 1 | $24 |
Products named: UPTRAVI, OFEV, DUPIXENT, FASENRA, Vest Therapy Und.
Industry payments across WI — which companies pay providers there.
